FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J. Díaz Osterman, David D. Schlaepfer, Edward A. Cordasco et al.|eLife|2019Cited by 142
Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancerNina R. Shah, David D. Schlaepfer, Isabelle Tancioni et al.|Gynecologic Oncology|2014Cited by 54
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J. Díaz Osterman, David D. Schlaepfer, Duygu Ozmadenci et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 21
Abstract 3157: An Rgnef (p190RhoGEF/Arhgef28) signaling axis regulates ovarian cancer progressionNichol Miller, David D. Schlaepfer, Isabelle Tancioni et al.|Cancer Research|2014Cited by 3
Author response: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J. Díaz Osterman, David D. Schlaepfer, Duygu Ozmadenci et al.|Unknown|2019Cited by 2